$0.9399
0.0274[3.00%]
At close: Apr 26
$0.9399
0[0.00%]
After Hours: 7:43PM EDT
bluebird bio
(NASDAQ:BLUE)bluebird bio Stock (NASDAQ:BLUE), Insider Trading Activity
bluebird bio: Insider buying and selling updated today.
Insider Shares Owned
1.821M
Insider Percentage Owned
0.94%
Institutional Shares Held
54.121M
Institutional Percentage Held
28.1%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 05, 2024 | Richard Colvin | CHIEF MEDICAL OFFICER | -6.77K | $1.53 | -$10.34K | SELL | -5.41% | 118.368K | Mar 01 | View |
| Mar 05, 2024 | Andrew Obenshain | PRESIDENT AND CEO | -6.095K | $1.53 | -$9.31K | SELL | -2.13% | 279.998K | Mar 04 | View |
| Mar 05, 2024 | Thomas Klima | SEE REMARKS | -4.573K | $1.53 | -$6.99K | SELL | -3.53% | 124.84K | Mar 04 | View |
| Feb 06, 2024 | Thomas Klima | SEE REMARKS | -2.714K | $0.90 | -$2.45K | SELL | -2.05% | 129.413K | Feb 05 | View |
| Feb 06, 2024 | Joseph Vittiglio | CHIEF BUSINESS & LEGAL OFFICER | -5.217K | $0.90 | -$4.71K | SELL | -10.43% | 44.783K | Feb 05 | View |
| Feb 06, 2024 | Andrew Obenshain | PRESIDENT AND CEO | -1.879K | $0.90 | -$1.70K | SELL | -0.65% | 286.093K | Feb 05 | View |
| Jan 09, 2024 | Andrew Obenshain | PRESIDENT AND CEO | -3.162K | $1.43 | -$4.52K | SELL | -1.09% | 287.972K | Jan 05 | View |
| Jan 09, 2024 | Richard Colvin | CHIEF MEDICAL OFFICER | -597 | $1.42 | -$844.75 | SELL | -0.47% | 125.138K | Jan 05 | View |
| Dec 08, 2023 | Christopher Krawtschuk | CHIEF FINANCIAL OFFICER | -4.526K | $4.52 | -$20.44K | SELL | -9.05% | 45.474K | Dec 06 | View |
| Nov 03, 2023 | Andrew Obenshain | PRESIDENT AND CEO | -807 | $3.17 | -$2.55K | SELL | -0.28% | 291.134K | Nov 03 | View |
| Nov 03, 2023 | Richard Colvin | CHIEF MEDICAL OFFICER | -2.343K | $2.98 | -$6.97K | SELL | -1.83% | 125.735K | Nov 02 | View |
| Sep 06, 2023 | Thomas Klima | SEE REMARKS | -922 | $3.79 | -$3.49K | SELL | -0.69% | 132.127K | Sep 05 | View |
| Aug 10, 2023 | Andrew Obenshain | PRESIDENT AND CEO | -16.929K | $3.54 | -$59.96K | SELL | -5.48% | 291.941K | Aug 10 | View |
| Jun 06, 2023 | Thomas J Klima | SEE REMARKS | -4.13K | $3.50 | -$14.45K | SELL | -3.01% | 133.049K | Jun 02 | View |
| Mar 09, 2023 | Elisabeth Leiderman | -1.004K | $6.46 | -$6.49K | SELL | -8.05% | 11.466K | Oct 17 | View | |
| Jan 13, 2023 | Andrew Obenshain | PRESIDENT AND CEO | -3.178K | $7.80 | -$24.80K | SELL | -1.29% | 242.69K | Jan 11 | View |
| Jan 13, 2023 | Richard A Colvin | CHIEF MEDICAL OFFICER | -557 | $7.80 | -$4.35K | SELL | -0.74% | 74.231K | Jan 11 | View |
| Jan 13, 2023 | Nick Leschly | -4.29K | $7.80 | -$33.48K | SELL | -1.05% | 403.149K | Jan 11 | View | |
| Nov 08, 2022 | Richard Colvin | CHIEF MEDICAL OFFICER | -218 | $6.41 | -$1.40K | SELL | -0.29% | 74.788K | Nov 04 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.